期刊文献+

以皮肤表现为主的原发性系统性淀粉样变病1例 被引量:2

下载PDF
导出
摘要 报道1例皮肤受累较突出的原发性系统性淀粉样变病。患者男,60岁,主要表现为头面部及肛周散在紫癜,近期出现心慌、气短。查体可见面部、颈部、腹部、肛周及口腔黏膜多发紫癜、紫红色瘀斑,部分融合,舌红肿大,可见齿痕。辅助检查:血清蛋白电泳可见M蛋白,24 h尿蛋白1.07 g,超声心动图示左房扩大,室间隔及左室后壁心肌厚度正常高限,左室舒张功能减退。皮肤镜表现为紫红色不规则斑块,边缘模糊,部分融合。皮肤病理:表皮轻度角化过度,棘层萎缩变薄,基底层色素增加。真皮浅中层可见淡红色淀粉样物质沉积,刚果红染色阳性。根据临床表现及皮肤组织病理结果,考虑原发性系统性淀粉样变。目前予泼尼松30 mg 1天1次口服,完善系统评估中,建议其转诊血液科。
出处 《皮肤性病诊疗学杂志》 2016年第1期40-42,共3页 Journal of Diagnosis and Therapy on Dermato-venereology
  • 相关文献

参考文献9

  • 1Merlini G, Palladini G. Amyloidosis: is a t'ure possibl,'? [J]. Ann Oncol, 2008, 19(Suppl4): 63-66.
  • 2Blancas-Mejia IJM, Ramirez-Alvarado M. Systemic amv- loidoses[ J]. Annu Rev Biochem, 2013(82): 745-774.
  • 3刘明辉,陈军.原发性淀粉样变性诊治进展[J].转化医学电子杂志,2014,1(1):44-47. 被引量:4
  • 4潘然,彭美雄,徐宏俊,陈周,杜娟,徐前喜,戴林,张建中.原发性系统性淀粉样变病1例[J].中国皮肤性病学杂志,2012,26(6):540-541. 被引量:7
  • 5Bolognia JL, Jon'izo JL, Schaffer JV. Dermatology[ M ] l,ondon : EI-sevier, 2012: 705.
  • 6Palladini G, Medini G. Cun'enl treatment of AI, amyloid- osis[ J] Haematologica, 2009, 94(8) : 1044-1048.
  • 7Dispenzierl A, Gertz MA, Kyle RA, et al. Serum ardi- ac troponins and N-terminal pro-brain natriuretic peptide: a stating system for primary systemic amyloidosis [J ]. J Cli Oncol, 2004, 22 (18) : 3751-3757.
  • 8卢瑞青,张晓红.口服大剂量美法仑化疗联合自体外周血干细胞移植治疗多发性骨髓瘤3例报告[J].实用肿瘤杂志,2007,22(4):348-350. 被引量:1
  • 9Sanehorawala V. High dose melphalan and aulologous pe- ripheral blood stem cell Iransplanlalion in AL amyloidsis [J]. Hematol Oncol Clin North Am, 2014, 28 (6) : 1131-1144.

二级参考文献10

  • 1陈伟,李薇,熊琳,黎静宜,赵颖,王琳,冉玉平.原发性系统性淀粉样变病1例报告并文献复习[J].中国误诊学杂志,2006,6(4):607-609. 被引量:4
  • 2Myeloma Trialists' Collaborative Group.Combination chemotherapy versus melphalan plus prednisone as treatment of multiple myeloma:an overview of 6,633 patients from 27 randomized trials[J].J Clin Oncol,1998,16(12):3832-3842.
  • 3Blade J,San Miguel JF,Fontanillas M,et al.Increased conventional chemotherapy does not improve survival in multiple myeloma:long-term results of two trials including 914 patients[J].Hematol J,2001,2(4):272-278.
  • 4McElwain TJ,Powles RL.High-dose intravenous melphalan for plasma-cell leukemia and myeloma[J].Lancet,1983,2(8354):822-824.
  • 5Vesole DH,Barlogie B,Jagannath S,et al.High-dose therapy for refractory multiple myeloma:Improved prognosis with better support care and double transplants[J].Blood,1994,84(3):950-956.
  • 6Moreau P,Facon T,Attal M,et al.Comparison of 200 mg/m2 melphalan and 8Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma:final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial[J].Blood,2002,99(3):731-735.
  • 7Hazenberg BP,van Gameren II, Bijzet J,et al. Diagnostic and therapeu- tic approach of systemic amyloidosis[ J . Netherlands Journal of Medi- cine,2004,62(d) :121 - 128.
  • 8Comenzo RL,Gellz MA. Autologous stem cell transplantation for prima- ry systemic amyloidosis[ J]. Blood ,2002,99( 12 ) :4276 -4282.
  • 9Dispenzieri A, Kyle RA, Lacy MQ. Superior survival in primary systemic amyloidosis patients undergoing pripheral blood stern cell transplant: a case control study [ J]. Blood,2004,103 ( 10 ) : 3960 - 3963.
  • 10林洁,段云,武永吉.原发性系统性淀粉样变性的诊断及治疗[J].中华血液学杂志,2003,24(6):335-336. 被引量:23

共引文献9

同被引文献8

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部